Defects in signaling by leptin, a hormone produced primarily by adipose tis
sue that informs the brain of the body's energy reserves, result in obesity
in mice and humans. However, the majority of obese humans do not have abno
rmalities in leptin or its receptor but instead exhibit leptin resistance t
hat could result from defects in downstream mediators of leptin action. Rec
ently, two potential downstream mediators, agouti-related protein (Agrp) an
d its receptor, the melanocortin-4 receptor (Mc4r), have been identified. A
grp and Mc4r are excellent candidates for human disorders of body weight re
gulation and represent promising targets for pharmacological intervention i
n the treatment of these disorders.